PERFROMANCE WEALTH PARTNERS, LLC Revance Therapeutics, Inc. Transaction History

PERFROMANCE WEALTH PARTNERS, LLC portfolio value:

$351,000
portfolio value

PERFROMANCE WEALTH PARTNERS, LLC quarter portfolio value change:

+95.37%
quarter

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 171K $27 13K
Q2 2022 share 0.00% 0 shares -74K $13.82 13K
Q1 2022 share 0.00% 0 shares 42K $19.5 13K
Q4 2021 share Increase 0.00% 13K shares 212K $16.49 13K